#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4.
1-1	0-2	4.	_	_	_	_

#Text=Medicinal Sesquiterpenes
2-1	3-12	Medicinal	person	new	_	_
2-2	13-27	Sesquiterpenes	person	new	_	_

#Text=Sesquiterpene biosynthesis normally begins in the cytosol via the C15 prenyl diphosphate FDP , which itself is derived from mevalonic acid and the MVA pathway .
3-1	28-41	Sesquiterpene	abstract[3]	new[3]	coref	23-5[150_3]
3-2	42-54	biosynthesis	abstract[3]	new[3]	_	_
3-3	55-63	normally	_	_	_	_
3-4	64-70	begins	_	_	_	_
3-5	71-73	in	_	_	_	_
3-6	74-77	the	substance[4]	new[4]	_	_
3-7	78-85	cytosol	substance[4]	new[4]	_	_
3-8	86-89	via	_	_	_	_
3-9	90-93	the	abstract[8]	new[8]	ana	3-16[0_8]
3-10	94-97	C15	substance|abstract[8]	new|new[8]	_	_
3-11	98-104	prenyl	abstract|abstract[8]	new|new[8]	_	_
3-12	105-116	diphosphate	person|abstract[8]	new|new[8]	_	_
3-13	117-120	FDP	abstract[8]	new[8]	_	_
3-14	121-122	,	abstract[8]	new[8]	_	_
3-15	123-128	which	abstract[8]	new[8]	_	_
3-16	129-135	itself	abstract[8]|abstract	new[8]|giv	coref	4-5
3-17	136-138	is	abstract[8]	new[8]	_	_
3-18	139-146	derived	abstract[8]	new[8]	_	_
3-19	147-151	from	abstract[8]	new[8]	_	_
3-20	152-161	mevalonic	abstract[8]|substance[10]	new[8]|new[10]	_	_
3-21	162-166	acid	abstract[8]|substance[10]	new[8]|new[10]	_	_
3-22	167-170	and	abstract[8]	new[8]	_	_
3-23	171-174	the	abstract[8]|abstract[12]	new[8]|new[12]	_	_
3-24	175-178	MVA	abstract[8]|abstract|abstract[12]	new[8]|new|new[12]	_	_
3-25	179-186	pathway	abstract[8]|abstract[12]	new[8]|new[12]	_	_
3-26	187-188	.	_	_	_	_

#Text=Sesquiterpene synthases act on FDP to yield hundreds of sesquiterpene hydrocarbons and alcohols based on dozens of carbon skeletons .
4-1	189-202	Sesquiterpene	abstract|abstract[14]	new|new[14]	coref|ana	4-10|5-1[0_14]
4-2	203-212	synthases	abstract[14]	new[14]	_	_
4-3	213-216	act	_	_	_	_
4-4	217-219	on	_	_	_	_
4-5	220-223	FDP	abstract	giv	coref	25-8
4-6	224-226	to	_	_	_	_
4-7	227-232	yield	_	_	_	_
4-8	233-241	hundreds	substance[17]	new[17]	coref	6-13[41_17]
4-9	242-244	of	substance[17]	new[17]	_	_
4-10	245-258	sesquiterpene	abstract|substance[17]	giv|new[17]	_	_
4-11	259-271	hydrocarbons	substance[17]	new[17]	_	_
4-12	272-275	and	_	_	_	_
4-13	276-284	alcohols	substance[18]	new[18]	_	_
4-14	285-290	based	substance[18]	new[18]	_	_
4-15	291-293	on	substance[18]	new[18]	_	_
4-16	294-300	dozens	substance[18]|object[20]	new[18]|new[20]	_	_
4-17	301-303	of	substance[18]|object[20]	new[18]|new[20]	_	_
4-18	304-310	carbon	substance[18]|substance|object[20]	new[18]|new|new[20]	coref	20-15
4-19	311-320	skeletons	substance[18]|object[20]	new[18]|new[20]	_	_
4-20	321-322	.	_	_	_	_

#Text=They are frequently responsible for familiar scents and flavors , for instance ginger ( gingerol ) , clove , cannabis , rosemary ( β-caryophyllene ) , patchouli ( patchoulol ) , sandalwood ( α-santalene ) , and rain ( geosmin , a bacterial sesquiterpene ) .
5-1	323-327	They	abstract	giv	_	_
5-2	328-331	are	_	_	_	_
5-3	332-342	frequently	_	_	_	_
5-4	343-354	responsible	_	_	_	_
5-5	355-358	for	_	_	_	_
5-6	359-367	familiar	abstract[22]	new[22]	_	_
5-7	368-374	scents	abstract[22]	new[22]	_	_
5-8	375-378	and	_	_	_	_
5-9	379-386	flavors	abstract[23]	new[23]	ana	6-1[0_23]
5-10	387-388	,	abstract[23]	new[23]	_	_
5-11	389-392	for	abstract[23]	new[23]	_	_
5-12	393-401	instance	abstract[23]|substance[24]	new[23]|new[24]	appos	5-15[0_24]
5-13	402-408	ginger	abstract[23]|substance[24]	new[23]|new[24]	_	_
5-14	409-410	(	_	_	_	_
5-15	411-419	gingerol	substance	giv	_	_
5-16	420-421	)	_	_	_	_
5-17	422-423	,	_	_	_	_
5-18	424-429	clove	plant	new	_	_
5-19	430-431	,	_	_	_	_
5-20	432-440	cannabis	plant	new	_	_
5-21	441-442	,	_	_	_	_
5-22	443-451	rosemary	plant	new	_	_
5-23	452-453	(	_	_	_	_
5-24	454-469	β-caryophyllene	substance	new	_	_
5-25	470-471	)	_	_	_	_
5-26	472-473	,	_	_	_	_
5-27	474-483	patchouli	plant	new	appos	5-29
5-28	484-485	(	_	_	_	_
5-29	486-496	patchoulol	plant	giv	_	_
5-30	497-498	)	_	_	_	_
5-31	499-500	,	_	_	_	_
5-32	501-511	sandalwood	substance	new	appos	5-34
5-33	512-513	(	_	_	_	_
5-34	514-525	α-santalene	substance	giv	_	_
5-35	526-527	)	_	_	_	_
5-36	528-529	,	_	_	_	_
5-37	530-533	and	_	_	_	_
5-38	534-538	rain	substance	new	appos	5-42[36_0]
5-39	539-540	(	_	_	_	_
5-40	541-548	geosmin	person	new	_	_
5-41	549-550	,	_	_	_	_
5-42	551-552	a	substance[36]	giv[36]	coref	7-9[0_36]
5-43	553-562	bacterial	substance[36]	giv[36]	_	_
5-44	563-576	sesquiterpene	substance[36]	giv[36]	_	_
5-45	577-578	)	_	_	_	_
5-46	579-580	.	_	_	_	_

#Text=They are the heaviest of the volatile terpenes under standard conditions ( diterpene hydrocarbons ordinarily require heating to form gases ) .
6-1	581-585	They	abstract	giv	_	_
6-2	586-589	are	_	_	_	_
6-3	590-593	the	_	_	_	_
6-4	594-602	heaviest	_	_	_	_
6-5	603-605	of	_	_	_	_
6-6	606-609	the	substance[38]	new[38]	_	_
6-7	610-618	volatile	substance[38]	new[38]	_	_
6-8	619-627	terpenes	substance[38]	new[38]	_	_
6-9	628-633	under	substance[38]	new[38]	_	_
6-10	634-642	standard	substance[38]|abstract[39]	new[38]|new[39]	_	_
6-11	643-653	conditions	substance[38]|abstract[39]	new[38]|new[39]	_	_
6-12	654-655	(	_	_	_	_
6-13	656-665	diterpene	abstract|substance[41]	new|giv[41]	_	_
6-14	666-678	hydrocarbons	substance[41]	giv[41]	_	_
6-15	679-689	ordinarily	_	_	_	_
6-16	690-697	require	_	_	_	_
6-17	698-705	heating	abstract	new	_	_
6-18	706-708	to	_	_	_	_
6-19	709-713	form	event	new	none|none	6-19[0_213]|20-14
6-20	714-719	gases	substance	new	_	_
6-21	720-721	)	_	_	_	_
6-22	722-723	.	_	_	_	_

#Text=Plant families known to be principal producers of sesquiterpene volatiles include the Lamiaceae , Geraniaceae , Rutaceae , Myrtaceae , Cannabaceae , and Gingeraceae .
7-1	724-729	Plant	organization[44]	new[44]	_	_
7-2	730-738	families	organization[44]	new[44]	_	_
7-3	739-744	known	organization[44]	new[44]	_	_
7-4	745-747	to	organization[44]	new[44]	_	_
7-5	748-750	be	organization[44]	new[44]	_	_
7-6	751-760	principal	organization[44]|person[45]	new[44]|new[45]	_	_
7-7	761-770	producers	organization[44]|person[45]	new[44]|new[45]	_	_
7-8	771-773	of	organization[44]|person[45]	new[44]|new[45]	_	_
7-9	774-787	sesquiterpene	organization[44]|person[45]|substance|substance[47]	new[44]|new[45]|giv|new[47]	coref	16-4
7-10	788-797	volatiles	organization[44]|person[45]|substance[47]	new[44]|new[45]|new[47]	_	_
7-11	798-805	include	_	_	_	_
7-12	806-809	the	animal[48]	new[48]	_	_
7-13	810-819	Lamiaceae	animal[48]	new[48]	_	_
7-14	820-821	,	_	_	_	_
7-15	822-833	Geraniaceae	person	new	_	_
7-16	834-835	,	_	_	_	_
7-17	836-844	Rutaceae	plant	new	_	_
7-18	845-846	,	_	_	_	_
7-19	847-856	Myrtaceae	animal	new	_	_
7-20	857-858	,	_	_	_	_
7-21	859-870	Cannabaceae	plant	new	_	_
7-22	871-872	,	_	_	_	_
7-23	873-876	and	_	_	_	_
7-24	877-888	Gingeraceae	plant	new	_	_
7-25	889-890	.	_	_	_	_

#Text=The use of these essential oils in traditional herbal medicine such as aromatherapy and Ayurvedic medicine is well documented .
8-1	891-894	The	event[54]	new[54]	coref	9-6[61_54]
8-2	895-898	use	event[54]	new[54]	_	_
8-3	899-901	of	event[54]	new[54]	_	_
8-4	902-907	these	event[54]|object[55]	new[54]|new[55]	ana	9-6[0_55]
8-5	908-917	essential	event[54]|object[55]	new[54]|new[55]	_	_
8-6	918-922	oils	event[54]|object[55]	new[54]|new[55]	_	_
8-7	923-925	in	event[54]	new[54]	_	_
8-8	926-937	traditional	event[54]|abstract[56]	new[54]|new[56]	coref	8-15[58_56]
8-9	938-944	herbal	event[54]|abstract[56]	new[54]|new[56]	_	_
8-10	945-953	medicine	event[54]|abstract[56]	new[54]|new[56]	_	_
8-11	954-958	such	event[54]|abstract[56]	new[54]|new[56]	_	_
8-12	959-961	as	event[54]|abstract[56]	new[54]|new[56]	_	_
8-13	962-974	aromatherapy	event[54]|abstract[56]|abstract	new[54]|new[56]|new	_	_
8-14	975-978	and	event[54]|abstract[56]	new[54]|new[56]	_	_
8-15	979-988	Ayurvedic	event[54]|abstract[56]|abstract[58]	new[54]|new[56]|giv[58]	coref	14-15[91_58]
8-16	989-997	medicine	event[54]|abstract[56]|abstract[58]	new[54]|new[56]|giv[58]	_	_
8-17	998-1000	is	_	_	_	_
8-18	1001-1005	well	_	_	_	_
8-19	1006-1016	documented	_	_	_	_
8-20	1017-1018	.	_	_	_	_

#Text=There is currently little evidence their use confers actual medical benefits , yet their use remains widespread due to their aesthetic , historical , and cultural significance .
9-1	1019-1024	There	_	_	_	_
9-2	1025-1027	is	_	_	_	_
9-3	1028-1037	currently	_	_	_	_
9-4	1038-1044	little	abstract[59]	new[59]	_	_
9-5	1045-1053	evidence	abstract[59]	new[59]	_	_
9-6	1054-1059	their	abstract[59]|object|event[61]	new[59]|giv|giv[61]	ana|coref	9-14|9-14[64_61]
9-7	1060-1063	use	abstract[59]|event[61]	new[59]|giv[61]	_	_
9-8	1064-1071	confers	abstract[59]	new[59]	_	_
9-9	1072-1078	actual	abstract[59]|abstract[62]	new[59]|new[62]	_	_
9-10	1079-1086	medical	abstract[59]|abstract[62]	new[59]|new[62]	_	_
9-11	1087-1095	benefits	abstract[59]|abstract[62]	new[59]|new[62]	_	_
9-12	1096-1097	,	_	_	_	_
9-13	1098-1101	yet	_	_	_	_
9-14	1102-1107	their	object|event[64]	giv|giv[64]	ana	9-20
9-15	1108-1111	use	event[64]	giv[64]	_	_
9-16	1112-1119	remains	_	_	_	_
9-17	1120-1130	widespread	_	_	_	_
9-18	1131-1134	due	_	_	_	_
9-19	1135-1137	to	_	_	_	_
9-20	1138-1143	their	object|abstract[66]	giv|new[66]	_	_
9-21	1144-1153	aesthetic	abstract[66]	new[66]	_	_
9-22	1154-1155	,	abstract[66]	new[66]	_	_
9-23	1156-1166	historical	abstract[66]	new[66]	_	_
9-24	1167-1168	,	abstract[66]	new[66]	_	_
9-25	1169-1172	and	abstract[66]	new[66]	_	_
9-26	1173-1181	cultural	abstract[66]	new[66]	_	_
9-27	1182-1194	significance	abstract[66]	new[66]	_	_
9-28	1195-1196	.	_	_	_	_

#Text=On the other hand , a number of highly functionalized , non-volatile sesquiterpenes of plant origin have demonstrated highly specific biological activity and have therefore been investigated for their clinical potential .
10-1	1197-1199	On	_	_	_	_
10-2	1200-1203	the	_	_	_	_
10-3	1204-1209	other	_	_	_	_
10-4	1210-1214	hand	_	_	_	_
10-5	1215-1216	,	_	_	_	_
10-6	1217-1218	a	substance[67]	new[67]	ana	10-29[0_67]
10-7	1219-1225	number	substance[67]	new[67]	_	_
10-8	1226-1228	of	substance[67]	new[67]	_	_
10-9	1229-1235	highly	substance[67]	new[67]	_	_
10-10	1236-1250	functionalized	substance[67]	new[67]	_	_
10-11	1251-1252	,	substance[67]	new[67]	_	_
10-12	1253-1265	non-volatile	substance[67]	new[67]	_	_
10-13	1266-1280	sesquiterpenes	substance[67]	new[67]	_	_
10-14	1281-1283	of	substance[67]	new[67]	_	_
10-15	1284-1289	plant	substance[67]|plant|abstract[69]	new[67]|new|new[69]	coref	11-7
10-16	1290-1296	origin	substance[67]|abstract[69]	new[67]|new[69]	_	_
10-17	1297-1301	have	_	_	_	_
10-18	1302-1314	demonstrated	_	_	_	_
10-19	1315-1321	highly	abstract[70]	new[70]	_	_
10-20	1322-1330	specific	abstract[70]	new[70]	_	_
10-21	1331-1341	biological	abstract[70]	new[70]	_	_
10-22	1342-1350	activity	abstract[70]	new[70]	_	_
10-23	1351-1354	and	_	_	_	_
10-24	1355-1359	have	_	_	_	_
10-25	1360-1369	therefore	_	_	_	_
10-26	1370-1374	been	_	_	_	_
10-27	1375-1387	investigated	_	_	_	_
10-28	1388-1391	for	_	_	_	_
10-29	1392-1397	their	substance|abstract[72]	giv|new[72]	_	_
10-30	1398-1406	clinical	abstract[72]	new[72]	_	_
10-31	1407-1416	potential	abstract[72]	new[72]	_	_
10-32	1417-1418	.	_	_	_	_

#Text=A selection of these medically useful plant sesquiterpenoids follows .
11-1	1419-1420	A	abstract[73]	new[73]	_	_
11-2	1421-1430	selection	abstract[73]	new[73]	_	_
11-3	1431-1433	of	abstract[73]	new[73]	_	_
11-4	1434-1439	these	abstract[73]|substance[75]	new[73]|new[75]	_	_
11-5	1440-1449	medically	abstract[73]|substance[75]	new[73]|new[75]	_	_
11-6	1450-1456	useful	abstract[73]|substance[75]	new[73]|new[75]	_	_
11-7	1457-1462	plant	abstract[73]|plant|substance[75]	new[73]|giv|new[75]	coref	28-7
11-8	1463-1479	sesquiterpenoids	abstract[73]|substance[75]	new[73]|new[75]	_	_
11-9	1480-1487	follows	_	_	_	_
11-10	1488-1489	.	_	_	_	_

#Text=4.1. Artemisinin
12-1	1490-1494	4.1.	_	_	_	_
12-2	1495-1506	Artemisinin	substance	new	coref	16-1

#Text=Wormwood ( Artemisia annua L. , or qinghaosu , Asteraceae ) is native to China and is the source of the sesquiterpene endoperoxide artemisinin , shown to be highly effective at treating malaria .
13-1	1507-1515	Wormwood	person	new	appos	13-3[78_0]
13-2	1516-1517	(	_	_	_	_
13-3	1518-1527	Artemisia	person[78]|person[79]	giv[78]|giv[79]	appos|appos	13-3[79_78]|13-8[0_79]
13-4	1528-1533	annua	person[78]|person[79]	giv[78]|giv[79]	_	_
13-5	1534-1536	L.	person[78]|person[79]	giv[78]|giv[79]	_	_
13-6	1537-1538	,	person[79]	giv[79]	_	_
13-7	1539-1541	or	person[79]	giv[79]	_	_
13-8	1542-1551	qinghaosu	person[79]|person	giv[79]|giv	_	_
13-9	1552-1553	,	_	_	_	_
13-10	1554-1564	Asteraceae	animal	new	_	_
13-11	1565-1566	)	_	_	_	_
13-12	1567-1569	is	_	_	_	_
13-13	1570-1576	native	_	_	_	_
13-14	1577-1579	to	_	_	_	_
13-15	1580-1585	China	place	new	_	_
13-16	1586-1589	and	_	_	_	_
13-17	1590-1592	is	_	_	_	_
13-18	1593-1596	the	substance[83]	new[83]	_	_
13-19	1597-1603	source	substance[83]	new[83]	_	_
13-20	1604-1606	of	substance[83]	new[83]	_	_
13-21	1607-1610	the	substance[83]|substance[85]	new[83]|new[85]	_	_
13-22	1611-1624	sesquiterpene	substance[83]|substance[85]	new[83]|new[85]	_	_
13-23	1625-1637	endoperoxide	substance[83]|substance|substance[85]	new[83]|new|new[85]	coref	16-9
13-24	1638-1649	artemisinin	substance[83]|substance[85]	new[83]|new[85]	_	_
13-25	1650-1651	,	substance[83]|substance[85]	new[83]|new[85]	_	_
13-26	1652-1657	shown	substance[83]|substance[85]	new[83]|new[85]	_	_
13-27	1658-1660	to	substance[83]|substance[85]	new[83]|new[85]	_	_
13-28	1661-1663	be	substance[83]|substance[85]	new[83]|new[85]	_	_
13-29	1664-1670	highly	substance[83]|substance[85]	new[83]|new[85]	_	_
13-30	1671-1680	effective	substance[83]|substance[85]	new[83]|new[85]	_	_
13-31	1681-1683	at	_	_	_	_
13-32	1684-1692	treating	_	_	_	_
13-33	1693-1700	malaria	abstract	new	coref	14-39
13-34	1701-1702	.	_	_	_	_

#Text=In the early 1970s , phytochemists such as Youyou Tu investigated plants used in traditional Chinese herbal medicine and identified the usefulness of the traditional remedy qinghaosu in eradicating Plasmodium spp . infections , the causative agent of malaria , for which she received a Nobel Prize in Medicine in 2015 .
14-1	1703-1705	In	_	_	_	_
14-2	1706-1709	the	time[87]	new[87]	_	_
14-3	1710-1715	early	time[87]	new[87]	_	_
14-4	1716-1721	1970s	time[87]	new[87]	_	_
14-5	1722-1723	,	_	_	_	_
14-6	1724-1737	phytochemists	person[88]	new[88]	_	_
14-7	1738-1742	such	person[88]	new[88]	_	_
14-8	1743-1745	as	person[88]	new[88]	_	_
14-9	1746-1752	Youyou	person[88]|person[89]	new[88]|new[89]	ana	14-43[0_89]
14-10	1753-1755	Tu	person[88]|person[89]	new[88]|new[89]	_	_
14-11	1756-1768	investigated	_	_	_	_
14-12	1769-1775	plants	plant[90]	new[90]	coref	24-20[0_90]
14-13	1776-1780	used	plant[90]	new[90]	_	_
14-14	1781-1783	in	plant[90]	new[90]	_	_
14-15	1784-1795	traditional	plant[90]|abstract[91]	new[90]|giv[91]	coref	14-49[0_91]
14-16	1796-1803	Chinese	plant[90]|abstract[91]	new[90]|giv[91]	_	_
14-17	1804-1810	herbal	plant[90]|abstract[91]	new[90]|giv[91]	_	_
14-18	1811-1819	medicine	plant[90]|abstract[91]	new[90]|giv[91]	_	_
14-19	1820-1823	and	_	_	_	_
14-20	1824-1834	identified	_	_	_	_
14-21	1835-1838	the	abstract[92]	new[92]	_	_
14-22	1839-1849	usefulness	abstract[92]	new[92]	_	_
14-23	1850-1852	of	abstract[92]	new[92]	_	_
14-24	1853-1856	the	abstract[92]|substance[93]|abstract[94]	new[92]|new[93]|new[94]	_	_
14-25	1857-1868	traditional	abstract[92]|substance[93]|abstract[94]	new[92]|new[93]|new[94]	_	_
14-26	1869-1875	remedy	abstract[92]|substance[93]|abstract[94]	new[92]|new[93]|new[94]	_	_
14-27	1876-1885	qinghaosu	abstract[92]|abstract[94]	new[92]|new[94]	_	_
14-28	1886-1888	in	_	_	_	_
14-29	1889-1900	eradicating	_	_	_	_
14-30	1901-1911	Plasmodium	substance|plant[96]|substance[97]	new|new[96]|new[97]	appos|coref|coref	14-35[98_97]|21-13|21-13[138_96]
14-31	1912-1915	spp	plant[96]|substance[97]	new[96]|new[97]	_	_
14-32	1916-1917	.	substance[97]	new[97]	_	_
14-33	1918-1928	infections	substance[97]	new[97]	_	_
14-34	1929-1930	,	_	_	_	_
14-35	1931-1934	the	substance[98]	giv[98]	_	_
14-36	1935-1944	causative	substance[98]	giv[98]	_	_
14-37	1945-1950	agent	substance[98]	giv[98]	_	_
14-38	1951-1953	of	substance[98]	giv[98]	_	_
14-39	1954-1961	malaria	substance[98]|abstract	giv[98]|giv	_	_
14-40	1962-1963	,	_	_	_	_
14-41	1964-1967	for	_	_	_	_
14-42	1968-1973	which	_	_	_	_
14-43	1974-1977	she	person	giv	_	_
14-44	1978-1986	received	_	_	_	_
14-45	1987-1988	a	abstract[102]	new[102]	_	_
14-46	1989-1994	Nobel	abstract|abstract[102]	new|new[102]	_	_
14-47	1995-2000	Prize	abstract[102]	new[102]	_	_
14-48	2001-2003	in	abstract[102]	new[102]	_	_
14-49	2004-2012	Medicine	abstract[102]|abstract	new[102]|giv	ana	15-1
14-50	2013-2015	in	_	_	_	_
14-51	2016-2020	2015	time	new	_	_
14-52	2021-2022	.	_	_	_	_

#Text=It is more effective against a broader range of life cycle stages of the apicomplexan parasite than traditional anti-malarials such as quinine .
15-1	2023-2025	It	abstract	giv	_	_
15-2	2026-2028	is	_	_	_	_
15-3	2029-2033	more	_	_	_	_
15-4	2034-2043	effective	_	_	_	_
15-5	2044-2051	against	_	_	_	_
15-6	2052-2053	a	abstract[106]	new[106]	_	_
15-7	2054-2061	broader	abstract[106]	new[106]	_	_
15-8	2062-2067	range	abstract[106]	new[106]	_	_
15-9	2068-2070	of	abstract[106]	new[106]	_	_
15-10	2071-2075	life	abstract[106]|abstract|abstract[109]	new[106]|new|new[109]	coref	23-28[156_109]
15-11	2076-2081	cycle	abstract[106]|abstract|abstract[109]	new[106]|new|new[109]	_	_
15-12	2082-2088	stages	abstract[106]|abstract[109]	new[106]|new[109]	_	_
15-13	2089-2091	of	abstract[106]|abstract[109]	new[106]|new[109]	_	_
15-14	2092-2095	the	abstract[106]|abstract[109]|animal[110]	new[106]|new[109]|new[110]	coref	22-7[141_110]
15-15	2096-2108	apicomplexan	abstract[106]|abstract[109]|animal[110]	new[106]|new[109]|new[110]	_	_
15-16	2109-2117	parasite	abstract[106]|abstract[109]|animal[110]	new[106]|new[109]|new[110]	_	_
15-17	2118-2122	than	_	_	_	_
15-18	2123-2134	traditional	substance[111]	new[111]	_	_
15-19	2135-2149	anti-malarials	substance[111]	new[111]	_	_
15-20	2150-2154	such	substance[111]	new[111]	_	_
15-21	2155-2157	as	substance[111]	new[111]	_	_
15-22	2158-2165	quinine	substance[111]|substance	new[111]|new	_	_
15-23	2166-2167	.	_	_	_	_

#Text=Artemisinin is a sesquiterpene lactone with an unusual endoperoxide ring which imparts its anti-malarial properties (
16-1	2168-2179	Artemisinin	substance	giv	coref	16-3[115_0]
16-2	2180-2182	is	_	_	_	_
16-3	2183-2184	a	substance[115]	giv[115]	ana	16-13[0_115]
16-4	2185-2198	sesquiterpene	substance|substance[115]	giv|giv[115]	_	_
16-5	2199-2206	lactone	substance[115]	giv[115]	_	_
16-6	2207-2211	with	substance[115]	giv[115]	_	_
16-7	2212-2214	an	substance[115]|object[117]	giv[115]|new[117]	coref	31-13[215_117]
16-8	2215-2222	unusual	substance[115]|object[117]	giv[115]|new[117]	_	_
16-9	2223-2235	endoperoxide	substance[115]|substance|object[117]	giv[115]|giv|new[117]	coref	20-7
16-10	2236-2240	ring	substance[115]|object[117]	giv[115]|new[117]	_	_
16-11	2241-2246	which	substance[115]|object[117]	giv[115]|new[117]	_	_
16-12	2247-2254	imparts	substance[115]|object[117]	giv[115]|new[117]	_	_
16-13	2255-2258	its	substance[115]|object[117]|substance|abstract[119]	giv[115]|new[117]|giv|new[119]	coref	21-11
16-14	2259-2272	anti-malarial	substance[115]|object[117]|abstract[119]	giv[115]|new[117]|new[119]	_	_
16-15	2273-2283	properties	substance[115]|object[117]|abstract[119]	giv[115]|new[117]|new[119]	_	_
16-16	2284-2285	(	_	_	_	_

#Text=Figure 6
17-1	2286-2292	Figure	abstract[120]	new[120]	coref	26-1[170_120]
17-2	2293-2294	6	abstract[120]	new[120]	_	_

#Text=) .
18-1	2295-2296	)	_	_	_	_
18-2	2297-2298	.	_	_	_	_

#Text=The mechanism of action is still unclear , and several possibilities have been proposed .
19-1	2299-2302	The	abstract[121]	new[121]	_	_
19-2	2303-2312	mechanism	abstract[121]	new[121]	_	_
19-3	2313-2315	of	abstract[121]	new[121]	_	_
19-4	2316-2322	action	abstract[121]|event	new[121]|new	_	_
19-5	2323-2325	is	_	_	_	_
19-6	2326-2331	still	_	_	_	_
19-7	2332-2339	unclear	_	_	_	_
19-8	2340-2341	,	_	_	_	_
19-9	2342-2345	and	_	_	_	_
19-10	2346-2353	several	abstract[123]	new[123]	_	_
19-11	2354-2367	possibilities	abstract[123]	new[123]	_	_
19-12	2368-2372	have	_	_	_	_
19-13	2373-2377	been	_	_	_	_
19-14	2378-2386	proposed	_	_	_	_
19-15	2387-2388	.	_	_	_	_

#Text=Most involve the degradation of the endoperoxide bridge in a heme-dependent process to form carbon centered radicals which then alkylate multiple targets including heme and proteins .
20-1	2389-2393	Most	_	_	_	_
20-2	2394-2401	involve	abstract|abstract	new|new	coref|none|none|none	21-1[133_0]|20-2[0_133]|20-2[0_218]|22-13
20-3	2402-2405	the	event[124]	new[124]	_	_
20-4	2406-2417	degradation	event[124]	new[124]	_	_
20-5	2418-2420	of	event[124]	new[124]	_	_
20-6	2421-2424	the	event[124]|object[126]	new[124]|new[126]	_	_
20-7	2425-2437	endoperoxide	event[124]|substance|object[126]	new[124]|giv|new[126]	coref	31-14
20-8	2438-2444	bridge	event[124]|object[126]	new[124]|new[126]	_	_
20-9	2445-2447	in	_	_	_	_
20-10	2448-2449	a	event[127]	new[127]	coref	32-6[217_127]
20-11	2450-2464	heme-dependent	event[127]	new[127]	_	_
20-12	2465-2472	process	event[127]	new[127]	_	_
20-13	2473-2475	to	_	_	_	_
20-14	2476-2480	form	event	new	coref	31-9[213_0]
20-15	2481-2487	carbon	substance|object[129]	giv|new[129]	_	_
20-16	2488-2496	centered	object[129]	new[129]	_	_
20-17	2497-2505	radicals	object[129]	new[129]	_	_
20-18	2506-2511	which	object[129]	new[129]	_	_
20-19	2512-2516	then	object[129]	new[129]	_	_
20-20	2517-2525	alkylate	object[129]	new[129]	_	_
20-21	2526-2534	multiple	object[129]|abstract[130]	new[129]|new[130]	_	_
20-22	2535-2542	targets	object[129]|abstract[130]	new[129]|new[130]	_	_
20-23	2543-2552	including	object[129]|abstract[130]	new[129]|new[130]	_	_
20-24	2553-2557	heme	object[129]|abstract[130]|substance	new[129]|new[130]|new	coref	21-4
20-25	2558-2561	and	object[129]|abstract[130]	new[129]|new[130]	_	_
20-26	2562-2570	proteins	object[129]|abstract[130]|substance	new[129]|new[130]|new	_	_
20-27	2571-2572	.	_	_	_	_

#Text=The involvement of heme is consistent with the specificity of artemisinin towards Plasmodium spp . .
21-1	2573-2576	The	abstract[133]	new[133]	_	_
21-2	2577-2588	involvement	abstract[133]	new[133]	_	_
21-3	2589-2591	of	abstract[133]	new[133]	_	_
21-4	2592-2596	heme	abstract[133]|substance	new[133]|giv	coref	22-19
21-5	2597-2599	is	_	_	_	_
21-6	2600-2610	consistent	_	_	_	_
21-7	2611-2615	with	_	_	_	_
21-8	2616-2619	the	abstract[135]	new[135]	_	_
21-9	2620-2631	specificity	abstract[135]	new[135]	_	_
21-10	2632-2634	of	abstract[135]	new[135]	_	_
21-11	2635-2646	artemisinin	abstract[135]|substance	new[135]|giv	coref	23-5
21-12	2647-2654	towards	abstract[135]	new[135]	_	_
21-13	2655-2665	Plasmodium	abstract[135]|substance|plant[138]	new[135]|giv|giv[138]	_	_
21-14	2666-2669	spp	abstract[135]|plant[138]	new[135]|giv[138]	_	_
21-15	2670-2671	.	_	_	_	_
21-16	2672-2673	.	_	_	_	_

#Text=The direct cause of toxicity to the parasite is unclear but may involve interference with the conversion of heme to hemozoin , although this hypothesis has been disputed ( and reviewed in reference ) .
22-1	2674-2677	The	abstract[139]	new[139]	_	_
22-2	2678-2684	direct	abstract[139]	new[139]	_	_
22-3	2685-2690	cause	abstract[139]	new[139]	_	_
22-4	2691-2693	of	abstract[139]	new[139]	_	_
22-5	2694-2702	toxicity	abstract[139]|abstract[140]	new[139]|new[140]	_	_
22-6	2703-2705	to	abstract[139]|abstract[140]	new[139]|new[140]	_	_
22-7	2706-2709	the	abstract[139]|abstract[140]|animal[141]	new[139]|new[140]|giv[141]	_	_
22-8	2710-2718	parasite	abstract[139]|abstract[140]|animal[141]	new[139]|new[140]|giv[141]	_	_
22-9	2719-2721	is	_	_	_	_
22-10	2722-2729	unclear	_	_	_	_
22-11	2730-2733	but	_	_	_	_
22-12	2734-2737	may	_	_	_	_
22-13	2738-2745	involve	abstract	new	none	31-8
22-14	2746-2758	interference	abstract[142]	new[142]	_	_
22-15	2759-2763	with	abstract[142]	new[142]	_	_
22-16	2764-2767	the	abstract[142]|event[143]	new[142]|new[143]	_	_
22-17	2768-2778	conversion	abstract[142]|event[143]	new[142]|new[143]	_	_
22-18	2779-2781	of	abstract[142]|event[143]	new[142]|new[143]	_	_
22-19	2782-2786	heme	abstract[142]|event[143]|substance	new[142]|new[143]|giv	_	_
22-20	2787-2789	to	abstract[142]|event[143]	new[142]|new[143]	_	_
22-21	2790-2798	hemozoin	abstract[142]|event[143]|substance	new[142]|new[143]|new	_	_
22-22	2799-2800	,	_	_	_	_
22-23	2801-2809	although	_	_	_	_
22-24	2810-2814	this	abstract[146]	new[146]	_	_
22-25	2815-2825	hypothesis	abstract[146]	new[146]	_	_
22-26	2826-2829	has	_	_	_	_
22-27	2830-2834	been	_	_	_	_
22-28	2835-2843	disputed	_	_	_	_
22-29	2844-2845	(	_	_	_	_
22-30	2846-2849	and	_	_	_	_
22-31	2850-2858	reviewed	_	_	_	_
22-32	2859-2861	in	_	_	_	_
22-33	2862-2871	reference	abstract	new	_	_
22-34	2872-2873	)	_	_	_	_
22-35	2874-2875	.	_	_	_	_

#Text=The early stages of artemisinin biosynthesis in glandular trichomes of A. annua are now understood at the biochemical and molecular levels , although the exact mechanism of the later stages remains unclear .
23-1	2876-2879	The	abstract[148]	new[148]	_	_
23-2	2880-2885	early	abstract[148]	new[148]	_	_
23-3	2886-2892	stages	abstract[148]	new[148]	_	_
23-4	2893-2895	of	abstract[148]	new[148]	_	_
23-5	2896-2907	artemisinin	abstract[148]|substance|abstract[150]	new[148]|giv|giv[150]	coref	24-16
23-6	2908-2920	biosynthesis	abstract[148]|abstract[150]	new[148]|giv[150]	_	_
23-7	2921-2923	in	abstract[148]	new[148]	_	_
23-8	2924-2933	glandular	abstract[148]|substance[151]	new[148]|new[151]	_	_
23-9	2934-2943	trichomes	abstract[148]|substance[151]	new[148]|new[151]	_	_
23-10	2944-2946	of	abstract[148]|substance[151]	new[148]|new[151]	_	_
23-11	2947-2949	A.	abstract[148]|substance[151]|person|animal[153]	new[148]|new[151]|new|new[153]	_	_
23-12	2950-2955	annua	abstract[148]|substance[151]|animal[153]	new[148]|new[151]|new[153]	_	_
23-13	2956-2959	are	_	_	_	_
23-14	2960-2963	now	_	_	_	_
23-15	2964-2974	understood	_	_	_	_
23-16	2975-2977	at	_	_	_	_
23-17	2978-2981	the	abstract[154]	new[154]	_	_
23-18	2982-2993	biochemical	abstract[154]	new[154]	_	_
23-19	2994-2997	and	abstract[154]	new[154]	_	_
23-20	2998-3007	molecular	abstract[154]	new[154]	_	_
23-21	3008-3014	levels	abstract[154]	new[154]	_	_
23-22	3015-3016	,	_	_	_	_
23-23	3017-3025	although	_	_	_	_
23-24	3026-3029	the	abstract[155]	new[155]	_	_
23-25	3030-3035	exact	abstract[155]	new[155]	_	_
23-26	3036-3045	mechanism	abstract[155]	new[155]	_	_
23-27	3046-3048	of	abstract[155]	new[155]	_	_
23-28	3049-3052	the	abstract[155]|abstract[156]	new[155]|giv[156]	_	_
23-29	3053-3058	later	abstract[155]|abstract[156]	new[155]|giv[156]	_	_
23-30	3059-3065	stages	abstract[155]|abstract[156]	new[155]|giv[156]	_	_
23-31	3066-3073	remains	_	_	_	_
23-32	3074-3081	unclear	_	_	_	_
23-33	3082-3083	.	_	_	_	_

#Text=Current efforts now focus on the regulation of this pathway in an effort to improve artemisinin production directly in plants .
24-1	3084-3091	Current	abstract[157]	new[157]	_	_
24-2	3092-3099	efforts	abstract[157]	new[157]	_	_
24-3	3100-3103	now	_	_	_	_
24-4	3104-3109	focus	_	_	_	_
24-5	3110-3112	on	_	_	_	_
24-6	3113-3116	the	abstract[158]	new[158]	_	_
24-7	3117-3127	regulation	abstract[158]	new[158]	_	_
24-8	3128-3130	of	abstract[158]	new[158]	_	_
24-9	3131-3135	this	abstract[158]|abstract[159]	new[158]|new[159]	coref	25-1[164_159]
24-10	3136-3143	pathway	abstract[158]|abstract[159]	new[158]|new[159]	_	_
24-11	3144-3146	in	_	_	_	_
24-12	3147-3149	an	abstract[160]	new[160]	_	_
24-13	3150-3156	effort	abstract[160]	new[160]	_	_
24-14	3157-3159	to	abstract[160]	new[160]	_	_
24-15	3160-3167	improve	abstract[160]	new[160]	_	_
24-16	3168-3179	artemisinin	abstract[160]|substance|abstract[162]	new[160]|giv|new[162]	_	_
24-17	3180-3190	production	abstract[160]|abstract[162]	new[160]|new[162]	_	_
24-18	3191-3199	directly	abstract[160]	new[160]	_	_
24-19	3200-3202	in	abstract[160]	new[160]	_	_
24-20	3203-3209	plants	abstract[160]|plant	new[160]|giv	_	_
24-21	3210-3211	.	_	_	_	_

#Text=The pathway begins with the conversion of FDP to amorpha-4,11-diene by amorpha-4,11-diene synthase (
25-1	3212-3215	The	abstract[164]	giv[164]	_	_
25-2	3216-3223	pathway	abstract[164]	giv[164]	_	_
25-3	3224-3230	begins	_	_	_	_
25-4	3231-3235	with	_	_	_	_
25-5	3236-3239	the	event[165]	new[165]	_	_
25-6	3240-3250	conversion	event[165]	new[165]	_	_
25-7	3251-3253	of	event[165]	new[165]	_	_
25-8	3254-3257	FDP	event[165]|abstract	new[165]|giv	_	_
25-9	3258-3260	to	event[165]	new[165]	_	_
25-10	3261-3279	amorpha-4,11-diene	event[165]|substance	new[165]|new	coref	25-12
25-11	3280-3282	by	_	_	_	_
25-12	3283-3301	amorpha-4,11-diene	substance|abstract[169]	giv|new[169]	coref	29-11
25-13	3302-3310	synthase	abstract[169]	new[169]	_	_
25-14	3311-3312	(	_	_	_	_

#Text=Figure 6
26-1	3313-3319	Figure	abstract[170]	giv[170]	_	_
26-2	3320-3321	6	abstract[170]	giv[170]	_	_

#Text=) .
27-1	3322-3323	)	_	_	_	_
27-2	3324-3325	.	_	_	_	_

#Text=Biochemical characterization and metabolite profiling of plant tissue indicated the presence of this olefin as well as its oxygenated derivatives artemisinic alcohol and aldehyde , dihydroartemisinic alcohol and aldehyde , and dihydroartemisinic acid .
28-1	3326-3337	Biochemical	abstract[171]	new[171]	_	_
28-2	3338-3354	characterization	abstract[171]	new[171]	_	_
28-3	3355-3358	and	_	_	_	_
28-4	3359-3369	metabolite	substance|abstract[173]	new|new[173]	_	_
28-5	3370-3379	profiling	abstract[173]	new[173]	_	_
28-6	3380-3382	of	abstract[173]	new[173]	_	_
28-7	3383-3388	plant	abstract[173]|plant|object[175]	new[173]|giv|new[175]	_	_
28-8	3389-3395	tissue	abstract[173]|object[175]	new[173]|new[175]	_	_
28-9	3396-3405	indicated	_	_	_	_
28-10	3406-3409	the	abstract[176]	new[176]	ana	28-18[0_176]
28-11	3410-3418	presence	abstract[176]	new[176]	_	_
28-12	3419-3421	of	abstract[176]	new[176]	_	_
28-13	3422-3426	this	abstract[176]|plant[177]	new[176]|new[177]	_	_
28-14	3427-3433	olefin	abstract[176]|plant[177]	new[176]|new[177]	_	_
28-15	3434-3436	as	_	_	_	_
28-16	3437-3441	well	_	_	_	_
28-17	3442-3444	as	_	_	_	_
28-18	3445-3448	its	abstract|substance[179]	giv|new[179]	_	_
28-19	3449-3459	oxygenated	substance[179]	new[179]	_	_
28-20	3460-3471	derivatives	substance[179]	new[179]	_	_
28-21	3472-3483	artemisinic	substance[180]	new[180]	_	_
28-22	3484-3491	alcohol	substance[180]	new[180]	_	_
28-23	3492-3495	and	_	_	_	_
28-24	3496-3504	aldehyde	substance	new	_	_
28-25	3505-3506	,	_	_	_	_
28-26	3507-3525	dihydroartemisinic	abstract|substance[183]|substance[184]	new|new[183]|new[184]	coref|coref|coref	28-32|29-13[191_183]|29-13[192_184]
28-27	3526-3533	alcohol	substance[183]|substance[184]	new[183]|new[184]	_	_
28-28	3534-3537	and	substance[184]	new[184]	_	_
28-29	3538-3546	aldehyde	substance[184]|substance	new[184]|new	coref	29-16
28-30	3547-3548	,	_	_	_	_
28-31	3549-3552	and	_	_	_	_
28-32	3553-3571	dihydroartemisinic	abstract|substance[187]	giv|new[187]	coref|coref	29-43|30-7[206_187]
28-33	3572-3576	acid	substance[187]	new[187]	_	_
28-34	3577-3578	.	_	_	_	_

#Text=Following the cloning and expression of CYP71AV1 , which converts amorpha-4,11-diene to artemisinic alcohol and aldehyde , Zhang et al. characterized the artemisinic aldehyde Δ11(13 ) reductase ( Double bond reductase 2 , Dbr2 ) , which preferentially reduces artemisinic aldehyde to dihydroartemisinic aldehyde .
29-1	3579-3588	Following	_	_	_	_
29-2	3589-3592	the	event[188]	new[188]	_	_
29-3	3593-3600	cloning	event[188]	new[188]	_	_
29-4	3601-3604	and	_	_	_	_
29-5	3605-3615	expression	abstract[189]	new[189]	_	_
29-6	3616-3618	of	abstract[189]	new[189]	_	_
29-7	3619-3627	CYP71AV1	abstract[189]	new[189]	_	_
29-8	3628-3629	,	abstract[189]	new[189]	_	_
29-9	3630-3635	which	abstract[189]	new[189]	_	_
29-10	3636-3644	converts	abstract[189]	new[189]	_	_
29-11	3645-3663	amorpha-4,11-diene	abstract[189]|substance	new[189]|giv	_	_
29-12	3664-3666	to	abstract[189]	new[189]	_	_
29-13	3667-3678	artemisinic	abstract[189]|substance[191]|substance[192]	new[189]|giv[191]|giv[192]	_	_
29-14	3679-3686	alcohol	abstract[189]|substance[191]|substance[192]	new[189]|giv[191]|giv[192]	_	_
29-15	3687-3690	and	abstract[189]|substance[192]	new[189]|giv[192]	_	_
29-16	3691-3699	aldehyde	abstract[189]|substance[192]|substance	new[189]|giv[192]|giv	coref	29-24
29-17	3700-3701	,	_	_	_	_
29-18	3702-3707	Zhang	person	new	_	_
29-19	3708-3710	et	_	_	_	_
29-20	3711-3714	al.	_	_	_	_
29-21	3715-3728	characterized	_	_	_	_
29-22	3729-3732	the	event[198]	new[198]	appos	29-29[200_198]
29-23	3733-3744	artemisinic	place|abstract[197]|event[198]	new|new[197]|new[198]	_	_
29-24	3745-3753	aldehyde	substance|abstract[197]|event[198]	giv|new[197]|new[198]	coref	29-40[202_0]
29-25	3754-3760	Δ11(13	abstract[197]|event[198]	new[197]|new[198]	_	_
29-26	3761-3762	)	event[198]	new[198]	_	_
29-27	3763-3772	reductase	event[198]	new[198]	_	_
29-28	3773-3774	(	_	_	_	_
29-29	3775-3781	Double	abstract[199]|event[200]	new[199]|giv[200]	_	_
29-30	3782-3786	bond	abstract[199]|event[200]	new[199]|giv[200]	_	_
29-31	3787-3796	reductase	event[200]	giv[200]	_	_
29-32	3797-3798	2	event[200]	giv[200]	_	_
29-33	3799-3800	,	_	_	_	_
29-34	3801-3805	Dbr2	abstract	new	_	_
29-35	3806-3807	)	_	_	_	_
29-36	3808-3809	,	_	_	_	_
29-37	3810-3815	which	_	_	_	_
29-38	3816-3830	preferentially	_	_	_	_
29-39	3831-3838	reduces	_	_	_	_
29-40	3839-3850	artemisinic	substance[202]	giv[202]	coref	29-43[204_202]
29-41	3851-3859	aldehyde	substance[202]	giv[202]	_	_
29-42	3860-3862	to	_	_	_	_
29-43	3863-3881	dihydroartemisinic	abstract|substance[204]	giv|giv[204]	coref|coref	30-10[0_204]|31-2
29-44	3882-3890	aldehyde	substance[204]	giv[204]	_	_
29-45	3891-3892	.	_	_	_	_

#Text=This substrate is then converted to dihydroartemisinic acid by aldehyde dehydrogenase 1 ( Aldh1 ) .
30-1	3893-3897	This	substance[205]	new[205]	_	_
30-2	3898-3907	substrate	substance[205]	new[205]	_	_
30-3	3908-3910	is	_	_	_	_
30-4	3911-3915	then	_	_	_	_
30-5	3916-3925	converted	_	_	_	_
30-6	3926-3928	to	_	_	_	_
30-7	3929-3947	dihydroartemisinic	substance[206]	giv[206]	coref	31-2[211_206]
30-8	3948-3952	acid	substance[206]	giv[206]	_	_
30-9	3953-3955	by	_	_	_	_
30-10	3956-3964	aldehyde	substance|substance[208]	giv|new[208]	appos	30-14[0_208]
30-11	3965-3978	dehydrogenase	substance[208]	new[208]	_	_
30-12	3979-3980	1	substance[208]	new[208]	_	_
30-13	3981-3982	(	_	_	_	_
30-14	3983-3988	Aldh1	substance	giv	_	_
30-15	3989-3990	)	_	_	_	_
30-16	3991-3992	.	_	_	_	_

#Text=From dihydroartemisinic acid , the remaining steps involve the photooxidative formation of the endoperoxide ring .
31-1	3993-3997	From	_	_	_	_
31-2	3998-4016	dihydroartemisinic	abstract|substance[211]	giv|giv[211]	_	_
31-3	4017-4021	acid	substance[211]	giv[211]	_	_
31-4	4022-4023	,	_	_	_	_
31-5	4024-4027	the	abstract[212]	new[212]	_	_
31-6	4028-4037	remaining	abstract[212]	new[212]	_	_
31-7	4038-4043	steps	abstract[212]	new[212]	_	_
31-8	4044-4051	involve	abstract	new	coref	32-11[218_0]
31-9	4052-4055	the	event[213]	new[213]	_	_
31-10	4056-4070	photooxidative	event[213]	new[213]	_	_
31-11	4071-4080	formation	event[213]	new[213]	_	_
31-12	4081-4083	of	event[213]	new[213]	_	_
31-13	4084-4087	the	event[213]|object[215]	new[213]|giv[215]	_	_
31-14	4088-4100	endoperoxide	event[213]|substance|object[215]	new[213]|giv|giv[215]	_	_
31-15	4101-4105	ring	event[213]|object[215]	new[213]|giv[215]	_	_
31-16	4106-4107	.	_	_	_	_

#Text=However , the details of this process , such as the potential involvement of additional enzyme activities , are currently unclear .
32-1	4108-4115	However	_	_	_	_
32-2	4116-4117	,	_	_	_	_
32-3	4118-4121	the	abstract[216]	new[216]	_	_
32-4	4122-4129	details	abstract[216]	new[216]	_	_
32-5	4130-4132	of	abstract[216]	new[216]	_	_
32-6	4133-4137	this	abstract[216]|event[217]	new[216]|giv[217]	_	_
32-7	4138-4145	process	abstract[216]|event[217]	new[216]|giv[217]	_	_
32-8	4146-4147	,	abstract[216]	new[216]	_	_
32-9	4148-4152	such	abstract[216]	new[216]	_	_
32-10	4153-4155	as	abstract[216]	new[216]	_	_
32-11	4156-4159	the	abstract[216]|abstract[218]	new[216]|new[218]	_	_
32-12	4160-4169	potential	abstract[216]|abstract[218]	new[216]|new[218]	_	_
32-13	4170-4181	involvement	abstract[216]|abstract[218]	new[216]|new[218]	_	_
32-14	4182-4184	of	abstract[216]|abstract[218]	new[216]|new[218]	_	_
32-15	4185-4195	additional	abstract[216]|abstract[218]|abstract[220]	new[216]|new[218]|new[220]	_	_
32-16	4196-4202	enzyme	abstract[216]|abstract[218]|substance|abstract[220]	new[216]|new[218]|new|new[220]	_	_
32-17	4203-4213	activities	abstract[216]|abstract[218]|abstract[220]	new[216]|new[218]|new[220]	_	_
32-18	4214-4215	,	_	_	_	_
32-19	4216-4219	are	_	_	_	_
32-20	4220-4229	currently	_	_	_	_
32-21	4230-4237	unclear	_	_	_	_
32-22	4238-4239	.	_	_	_	_
